chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Noticed that I had shortness of breath when loading my car to go to for Thanksgiving on the 24th.  It got progressively worse and on the 1st of December it was so bad that I could barely climb a flight of stairs without extreme loss of breath.  I call my husband's heart doctor, Dr, and made an appt. to see him on Friday afternoon.  I also had an appt. to see my regular physician for my yearly physical.  I reported my symptoms to her , but called Dr to see what he would want me to do.  His nurse suggested that I go to the ER right the.  I did and was diagnosed with blood clots in my lungs.   The "out of breath" happens when I walk from one of my house to the end or if I try and try a half glass of water. EXTREME loss of breath happens when I really exert myself physically such as climbing stair.   I DID NOT HAVE THIS CONDITION BEFORE I GOT MY MODERNA BOOSTER! I am pro Vaccination but I repeat I did not have this condition before I received the Moderna booster. The CDC says that have one case of something like this so far. I wonder how many other people are out there they may have milder blood clots than mine and are just say, not feeling well.  And the hospital said my heart was fine, blood gases normal and blood work also. Please feel free to contact them for my results!!
Patient presented with "palpitations". VS obtained and patient observed for 15 minutes and she returned to work.
neck spasms, severe pain, nausea, shooting pain from neck to injection site on left arm, including injection site
Patient c/o dizziness, cooled pale, shaking. VS taken 127/77- P.92 Resp 24 closely monitored in ER. Returned after few minutes, MD notified.
Site: Pain at Injection Site-Medium, Additional Details: Shoulder pain that is dull and constant.
Red scratch marks from and over injection site; Headache; Vaccination site redness; This spontaneous report was received from a pharmacy student, reporting on a male patient of unknown age. Information regarding the patient's medical history, concurrent conditions or concomitant medications was not provided.  On 10-NOV-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), pre-filled syringe, at a dose of 0.5 milliliter, subcutaneously for prophylaxis (lot # T021485, which was verified to be a valid lot number, expiration date reported and, upon internal validation, established as 15-MAR-2022).  On an unspecified date in November 2020, the patient experienced headache, redness at the injection site and red scratch marks from and over injection site. It was unknown by the reporter when this started exactly or how long, if treatment was given for the events or if laboratory diagnostics/studies were performed. The patient did not seek medical attention. The outcome of scratch, vaccination site erythema and headache was unknown.   The reporter considered headache, scratch and vaccination site erythema were caused by Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23). combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T021485; expirationdate: 15-MAR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
CHRONIC CHEST PAINS; SHORTNESS OF BREATH, NAUSEA all occurring in any physically involved activity such as walking, climbing the stairs, and wieght lifting.
No additional AE; Medical Tech calls to report vaccine given during an excursion.  No PQC. No further AE  TE Case02454494; This spontaneous report was received from the consumer referring to a patient of unspecified age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication.  On unspecified day, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot number W038815 expiration date: 04-JUN-2023, (strength, route of administration and vaccination site were not reported).  On 16-AUG-2023, the patient experienced fever (pyrexia).   The reporter did not provide causality assessment between the events and the suspect therapies.
Pt recvd vax 21FEB94 & 21MAR94; 16MAR94 devel elevated WBC Count, lymphadenopathy & neck stiffness; f/u info revealed that pt dx w/non-Hodgkin's lymphoma; nurse felt vax & the lymphadenopathy were not related
Information has been received from a physician concerning a 15 year old patient who on an unknown date was vaccinated with a dose of PNEUMOVAX 23 (lot # not reported). The reporter stated that after receiving PNEUMOVAX 23 the patient developed an acute disseminated encephalomyelitis. At the time of reporting, the outcome of the patient was unknown. It was unknown if the patient sought medical attention. The reporter was not the patient's physician. Upon internal review, acute disseminated encephalomyelitis was determined to be an other important medical event. Additional information has been requested.
fever of 104.5 R; very fussy for 2 hrs p/vax, lip shivering, lethargic acting;
Atrial fibrillation with rapid ventricular response. Patient who was discharged form the hospital yesterday for atrial fib with RVR reports to the clinic today c/o dizziness.  Metoprolol and digoxin where added during her last hospitalizations.  Pt states she went home and felt ok.  This morning she as had dizziness, worse when sitting up.  She denies any chest pain.   She occasionally has some shortness of breath.   She has not eaten today due to dizziness. Admitted for weakness/Dizziness. But we will for now treat her as Uncomplicated cystitis to complete with Cefdinir X total 5 days.   She is refusing PT/OT eval at this time and states she has no problem with Ambulation.  Her warfarin dose to be adjusted as INR this am is 3.1, Likely Interaction with Ceftriaxone. ED visit 7 days later for dizziness - treated and released. Hospital admission and ED visit within 6 weeks of receiving the COVID vaccine.
Patient stated she had severe redness and swelling of arm vaccine was injected in all the way down to elbow. Also reported that the arm was very warm. Said this began day after vaccination and resolved in 1-2 days.
Received DTAP and IPV on 09/13/2005, redness, swelling at injection site noted 09/15/2005, fever 09/14/2005.
Interchange of vaccine products; COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Sep2022 at 11:00 as dose 5 (booster), single (Lot number: G25342) at the age of 76 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 24Apr2022 as dose 4 (booster), single (Lot number: O56M21A), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Osteoporosis." (unspecified if ongoing), notes: Other medical history Osteoporosis. Concomitant medication(s) included: TESTOSTERONE, start date: 01Jan2022, stop date: 21Nov2022; CHLORTALIDONE, start date: 01Jan2022, stop date: 21Nov2022; ALENDRONATE, start date: 01Jan2022, stop date: 20Nov2022; POTASSIUM CHLORIDE, start date: 01Jan2022, stop date: 21Nov2022. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Interchange of vaccine products "; COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18Nov2022) Positive, notes: Tested positive 18Nov2022.  Clinical course: Patient received other medication in 2week. He received no treatment and had no known allergies.  Follow-up attempts are completed. No further information is expected.
Delayed itchy,warm rash; Redness; The area was Warm to touch; Spread from injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (Delayed itchy,warm rash), ERYTHEMA (Redness), VACCINATION SITE WARMTH (The area was Warm to touch) and VACCINATION SITE RASH (Spread from injection site) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A2119) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced RASH PRURITIC (Delayed itchy,warm rash), ERYTHEMA (Redness), VACCINATION SITE WARMTH (The area was Warm to touch) and VACCINATION SITE RASH (Spread from injection site). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) at a dose of 500 mg. At the time of the report, RASH PRURITIC (Delayed itchy,warm rash) had resolved, ERYTHEMA (Redness) had not resolved and VACCINATION SITE WARMTH (The area was Warm to touch) and VACCINATION SITE RASH (Spread from injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product was reported.
pt recv vax 18OCT95 & 19JUN97 pt devel a mild varicella rash that consisted of a few scattered lesions over body & face;
Severe Herpes simplex vulvovaginitis outbreak 24 hours after second Moderna covid-19 vaccination with prolonged course unresponsive to antiviral therapy.
I had severe mastitis acne. It started the day after the first and second vaccine and ended exactly two weeks later.   It left horrible scars on my face even though it is now gone.   I am due to give birth to my fourth child on 10/02/2022
Chills; Headache; Fever 101.3; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (Headache), MYALGIA (Sore arm) and PYREXIA (Fever 101.3) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) and IBUPROFEN (MOTRIN [IBUPROFEN]) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (Sore arm). On 06-Feb-2021, the patient experienced CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever 101.3). On 08-Feb-2021, CHILLS (Chills) and PYREXIA (Fever 101.3) had resolved. At the time of the report, HEADACHE (Headache) and MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
This case involves a 15-year-old male patient receiving INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] mistakenly (product administered to patient of inappropriate age). The patient medical history, past medical treatment, vaccination, concomitant medication, and family history were not provided. On 24-Nov-2021, the patient received a 0.5 mL total dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [frequency: once, strength: standard, lot QFAA2154, expiry date: 30-Jun-2022] via intramuscular route in the right deltoid for prophylactic vaccination. It was an actual medication error case due to Inappropriate age at vaccine administration (latency: same day). It was reported "doctor states that a 15-year-old patient mistakenly received a FLUBLOK QUADRIVALENT vaccination in his practice on 24NOV2021. Doctor asked if FLUBLOK QUADRIVALENT would give as strong of a response for this patient as other age-appropriate flu vaccines. Doctor also asked if there were any side effects or warnings that he needed to be aware of for this patient." At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Beginning on December 18th, I noticed that my daughter's head would shake uncontrollably while being fully supported. I figured it was normal baby shakes and was told that by multiple people not to worry. As December came to an end, I noticed she would blank out and when she would come back to reality, patient's body would vibrate. Starting December 31, 2019 - I noticed her arms and legs would jerk a bit more often when sleeping. I called and canceled her vaccinations on January 2nd and when asked why I told the nurse about the shaking and vibrating. We met with staff on January 3, 2019 to discuss what was going on. We scheduled an EEG for January 17th. It is now February 6, 2020 and I have yet to receive any information/results of the test. I have called multiple times and now found out the neurologist has been on vacation and hasn't been able to read it. Patient met with her pediatrician, staff on  January 29, 2019 for her wellness check. She referred us to the same neurologist as Patient continues to have episodes (have not heard from them to schedule an appointment). Refused to vaccinate any further with shots, however Patient did receive last dose of Rotavirus to complete that series.
Patient  has 3 red spots on her right arm that are warm to the touch and the size of a 50 cent piece.  She also has redness in the area that her immunization was given. Patient was evaluated and diagnosed with erythema nodosum.
PATIENT DEVELOPED A BLOTCHY, ITCHY RASH ON UPPER ARM.
Side effects included: injection area pain (left arm) radiating across neck and shoulders to left arm, body aches, tiredness, headaches
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated 3with a dose of ZOSTAVAX (lot number and expiration date were not provided). No concomitant therapies were reported. The reporting pharmacist stated that when he went to inject the vaccine, it leaked out the end of the barrel (incorrect dose administered and product container issue). The pharmacist believed the needle was on tight but maybe it came loose in the patient's arm (needle issue). Additional information has been requested.
Systemic: patient had no reactions-Mild, Additional Details:  there were no symptoms reported  spoke to the patient
The patient presented with weakness and numbness of lower extremities, consistent with Guillain Barre syndrome
Woke up fatigued with heavy limbs. Went to work where it progressed to dizziness, heavy chest (like a panic attack), and thighs became increasingly tired, sore, and weak. Despite taking time off work to rest, thigh muscles remained sore, weak, and muscles began twitching. This professed to calves in following days.  Overall body weakness noted, especially neck and arms. When any muscles are challenged they are susceptible to weakness, soreness, and muscle twitching, including arms, mid and upper back, abdominal muscles, groin muscles, and once the left side of the tongue. Symptoms continue to present. Symptoms dissipate with continued rest and return from cumulative activity, sometimes over the course of a few days.
patient received fluzone vacine this past thursday 9/23/2021. upper leg redness/swelling/pain/warmth sensation of the skin started on 9/25/2021. no fever. no myalgia. no vomiting. no headache. no flu like symptoms. unknown mosquito or insect bite.
Woke up at 1:30am with stomach pain, then chills followed by uncontrollable shaking - No fever - Left arm pain and constant head ache for 36hrs after second vaccine - No reaction after the first round of vaccine
gave both PNEUMOVAX and FLUVIRIN in same arm b/c of mastectomy-given about 3 inches apart; started w/redness/heat at injection site. Pt went to ER and diagnosed w/infection @ site of immunization. Pt said it was the flu vaccine b/c she remembers the PNEUMOVAX being given higher up on the arm.
Injection site soreness, whole body aches/soreness. 12 hours after injection.
Dose administered past the published expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered past the published expiry date) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered past the published expiry date). On 26-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered past the published expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was reported.
DIzziness was first. Then, I became very disoriented, and experienced extreme psychadelic effects.  I was not able to stand up, and had trouble speaking.  This was scarier than any pain drugs or other experiences.  I was incapacitated for about 6 hours, and finally fell asleep.  The next day, I was still unable to drive or work, requiring my first sick day in 3 years.
10 days post vax, the pt developed a fever to 105 and rash. Fever was brief and relieved by Tylenol.
Pt had varicella immunization on 08/08/1997. He broke out on 04/07/05 with blisters. Came to doctor 04/08/2005 for verification. Diagnosed with varicella.
Narrative:  88yo male patient with CURRENT PROBLEM LIST: Code Description Z85.46 History of malignant neoplasm of prostate (SCT 428262008) I67.9 Cerebrovascular disease (SCT 62914000) I48.20 Chronic atrial fibrillation (SCT 426749004) M10.9 Gout (SCT 90560007) N18.30 Chronic kidney disease stage 3 (SCT 433144002) G47.33 Obstructive sleep apnea of adult (SCT 1101000119103) D64.9 Anemia (SCT 271737000) J44.9 Chronic obstructive lung disease (SCT 13645005) I31.4 Cardiac tamponade (SCT 35304003) N40.1 Benign prostatic hypertrophy without outflow obstruction (SCT 254902007) E78.5 Hyperlipidemia (SCT 55822004) I10. Benign essential hypertension (SCT 38341003) died at home on 10/30/2021 during skilled home health . Pt had received covid vaccines on 1/19/21 & 2/23/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.
Myalgia, Arthraliga, Fever, ErythemaMultiform, NauseaVomiting, sore arm Narrative: Fever 102.9; arm pain, myalgia, arthralgia, nauseated; taking APAP/ibuprofen.
The spontaneous report was received from a physician and refers to an unspecified patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was reported. On 14-JUN-2016, the patient was vaccinated with one improperly stored dose of RECOMBIVAX HB lot # L033343, expiration date 13-SEP-2017 (strength, dose, route of administration and anatomical location were not provided). No adverse effects were reported. The vaccine was exposed for 35 Fahrenheit degrees for 1 hour on 29-APR-2016, for 33 Fahrenheit degrees for 1 hour and 30 minutes on 18-MAY-2016 and for 21.9 Fahrenheit degrees for 1 hour on 14-JUN-2016 (3 hours and 30 minutes in total). The vaccine was back in range. This was data logger issue. There were no previous excursions. This is one of two reports received from the same source. Additional information has been requested.
Information has been received from a RN concerning a 16 month old female who on 30-JUL-03 was vaccinated SC with a first dose of 0.5ml VARIVAX (Merck). Concomitant vaccinations given on that same day included a fourth dose of PNEUMOVAX 23 (manf unspecified) and a fourth dose of DTP (manf unk). Almost immediately after the injection the patient experienced hives and redness around the injection site. Unspecified medical attention was sought, no diagnostic or laboratory tests were performed. The RN reported that the patient has recovered. The reporter included an immunization summary: first, second and third doses of DTP given on 13-MAY-02, 17-JUL-02 and 26-SEP-02, respectively; first, second, third and fourth doses of Hib conj vaccine (unspecified carrier) on 25-APR-02, 13-MAY-02, 17-JUL-02 and 26-SEP-02, respectively; the first, second, and third doses of hep B virus vaccine rHBsAg (yeast) (manf unspecified); given on 06-MAR-02, 08-APR-02 and 03-DEC-02, respectively; the first, second and third doses of poliovirus vaccine inactivated (unspecified) given on 13-MAY-02, 17-JUL-02 and 26-SEP-02, respectively; and the first, second and third doses of pneumococcal 23v polysaccharide vaccine (manf unspecified) given on 13-MAY-02, 17-JUL-02 and 26-SEP-02, respectively. No product quality complaint was involved. Additional information has been requested.
I still have the symptoms which have been very mild but I'm getting better. I'm on PAXLOVID. I thought it was an allergy because I had a runny nose and dry cough. Also with itchy eyes and ears. My head is less stuffed up. I also had a huge swollen lymph node on the same side of the injection site on my neck after the vaccine that appeared 1 day after. It lasted for about a month. On the 20th of July I had the Tdap vaccination.